Drug Testing Lawsuit

A federal court in Nigeria has postponed criminal and civil cases against U.S. drugmaker Pfizer, Reuters reports. The Post's Joe Stephens reported in May that Nigerian authorities had filed legal actions in state and federal courts alleging that Pfizer's clinical trial of an antibiotic known as Trovan led to the deaths of 11 children and injured 189 others. Pfizer has argued that the drug trial did no harm and may have saved lives during a 1996 meningitis epidemic. The adjournment in the criminal case was to allow the court time to decide whether Pfizer should be served criminal summons. Separate civil and criminal actions against the company are also underway in a Nigerian state court. The clinical drug trials were the subject of a 2000 Washington Post investigation into the poorly regulated world of corporate drug trials.
By The Editors |
November 27, 2007; 10:29 AM ET
Previous: Investigations Elsewhere |
Next: Former N.C. Chief Justice Takes on Bullet Case








If you have solid tips, news or documents on potential ethical violations or abuses of power, we want to know. Send us your suggestions.

Unfortunately I believe that we are limited in what we can focus on. I think that if we proceed with the partisan sideshow of prosecuting Bush admin. officials, healthcare will get lost in the brouhaha.
The Washington Post's permanent investigative unit was set up in 1982 under Bob Woodward.
We encourage users to analyze, comment on and even challenge washingtonpost.com's articles, blogs, reviews and multimedia features.
User reviews and comments that include profanity or personal attacks or other inappropriate comments or material will be removed from the site. Additionally, entries that are unsigned or contain "signatures" by someone other than the actual author will be removed. Finally, we will take steps to block users who violate any of our posting standards, terms of use or privacy policies or any other policies governing this site. Please review the full rules governing commentaries and discussions.